SARAH DIMARTINO: Open Payments
NPI 1992467807 · FAYETTEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$449 in 20 payments from 9 companies in 2025. Trend: 2023 $1,095 · 2024 $608 · 2025 $449
Food & beverage: $449
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 4 | $109 |
| ABBVIE INC. | 3 | $64 |
| Janssen Biotech, Inc. | 2 | $62 |
| Aimmune Therapeutics, Inc. | 2 | $46 |
| GENZYME CORPORATION | 2 | $43 |
| Madrigal Pharmaceuticals | 2 | $40 |
| Gilead Sciences, Inc. | 1 | $32 |
| Phathom Pharmaceuticals, Inc. | 3 | $31 |
| Regeneron Healthcare Solutions, Inc. | 1 | $23 |
Products named: IBSRELA, DUPIXENT, TREMFYA, ZENPEP, REZDIFFRA, VOQUEZNA, MAVYRET, RINVOQ.
Industry payments across NC — which companies pay providers there.
